Navigation Links
InspireMD Reports Financial Results for Quarter Ended September 30, 2013
Date:11/11/2013

eptember 30, 2013 Financial ResultsRevenue for the quarter ended September 30, 2013 was $1.6 million, an increase of 205% compared to $0.5 million for the same period in 2012.  The increase year over year reflects the positive impact of recent steps taken to stabilize the global distribution strategy and the early success of targeted selling activities in Brazil as well as select European countries.

Gross profit for the quarter ended September 30, 2013 totaled $0.8 million, an increase of 187% compared to $0.3 million for same period in 2012. The increase in gross profit is attributable to an increase in revenue of approximately $1.1 million, as described above, partially offset by an increase in cost of revenues of approximately $0.5 million. Gross margin for the three months ended September 30, 2013 was 51.7%, a decrease from 54.8% in the three months ended September 30, 2012. If the non-recurring effects of the consolidation of our manufacturing facilities in the three months ended September 30, 2013 are removed, gross margin for the three months ended September 30, 2013 would have been 63.1%.

Total operating expenses for the quarter ended September 30, 2013 were $4.7 million, an increase of 31.7% compared to $3.6 million for the same period in 2012. The increase was primarily due to an increase in startup costs associated with initiating the MASTER II trial, as well as increased sales and marketing expenses, as the Company begins to build the appropriate sales infrastructure for future growth.

The loss from operations for the quarter ended September 30, 2013 was $3.9 million, an increase of 18.4% compared to a loss of $3.3 million for the same period in 2012.

Total financial expenses for the quarter ended September 30, 2013 were $0.1 million, a decrease of 98.6% compared to $4.2 million in the same period in 2012. The decrease in financial expenses resulted primarily from the absence of any non-cash revaluations of our warrants
'/>"/>

SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Capnia, Inc. (NASDAQ: ... medical diagnostics based on its proprietary Sensalyze™ Technology ... announced financial results for the third quarter and ... "Following the completion of our initial public offering ... the recently initiated CoSense® commercial launch," said Anish ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last ... the site now known as the leading online black ... seen explosive growth in its offering of drugs and ... Alliance show the takedowns did succeed in lowering the ... last review of the markets in August. But some ...
(Date:12/19/2014)... robust development with the growth pace keeping at 20%-30% in ... the size of China separating membrane ... to 16.3%. It is projected that China ... around 20% in the upcoming years and that the figure ... An integrated membrane industrial system has taken shape in ...
Breaking Medicine Technology:Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... 22, 2011 Reportlinker.com announces that ... available in its catalogue: ... Manufacturing, Research And Packaging: Focus on ... http://www.reportlinker.com/p0619263/Global-Markets-for-Contract-Pharmaceutical-Manufacturing-Research-And-Packaging-Focus-on-Emerging-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing REPORT ...
... Sept. 22, 2011 Reportlinker.com announces that a ... catalogue: Generic Drugs: The Global ... THIS REPORT CONTAINS ... employed by companies specializing in generics to meet ...
Cached Medicine Technology:Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 2Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 3Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 4Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 5Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 6Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 7Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 8Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 9Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 10Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 11Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 12Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 13Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 14Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 15Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 16Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 17Generic Drugs: The Global Market--Focus on Asia 2Generic Drugs: The Global Market--Focus on Asia 3Generic Drugs: The Global Market--Focus on Asia 4Generic Drugs: The Global Market--Focus on Asia 5Generic Drugs: The Global Market--Focus on Asia 6Generic Drugs: The Global Market--Focus on Asia 7Generic Drugs: The Global Market--Focus on Asia 8Generic Drugs: The Global Market--Focus on Asia 9
(Date:12/19/2014)... 19, 2014 If you have ever ... breathing, you probably wished you had an arsenal of ... cystic fibrosis, and other breathing disorders. Currently, the only ... avoiding triggers, but other common treatments do exist. ... in San Antonio, TX, 34 asthma educators responded to ...
(Date:12/19/2014)... December 19, 2014 Slone ... diagnostic, personalized medicine, healthcare information technology, and laboratory ... position of Chief Operating Officer. The announcement comes ... marked by a strengthened presence in Boston and ... "Leslie lives and breathes the client experience," said ...
(Date:12/19/2014)... This is a professional and in-depth ... industry with a focus on the Chinese market. The ... the Gliquidone manufacturers and is a valuable source of ... the industry. , Firstly, the report provides a basic ... manufacturing technology. Then, the report explores the international and ...
(Date:12/19/2014)... December 19, 2014 The Hermitage ... club in Southern Vermont’s Deerfield Valley, announced today that ... by classic rock songs. , Three time Grammy ... a private concert followed by a trail naming ceremony. ... trail names include: “I’m Alright” the theme song for ...
(Date:12/19/2014)... new study suggests a possible link between certain menopause ... sweats -- and higher rates of hip fractures and ... affecting about 60 percent of women. The hormonal changes ... then face a higher risk of weakened bones and ... or severe menopausal symptoms are more likely to have ...
Breaking Medicine News(10 mins):Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 2Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2
... Thailand who was infected by H5N1 bird flu virus and managed ... years old Pranom Thongchan, of Srisomboon, central Thailand, tells her horrific ... was her niece who coughed blood as she passed away in ... attacked her sister, the girl's mother, and she was dead. After ...
... gene, Sipa1, with an amino acid polymorphism that ... often the result of metastasis rather than the ... that the genetic background of the host can ... transgene in various strains of inbred mice and ...
... on mammograms. There are calcium deposits in the media ... called M?nckeberg medial// calcific sclerosis or medial arterial calcification. ... diabetes and cardiovascular risk, but there are few reports ... in Volume 18 (6) of Journal of Diabetes and ...
... meats, red meat and pork can enhance the risk of ... October 5 issue of the Journal of the National Cancer ... of exocrine pancreatic cancer, but previous findings have been inconsistent. ... cholesterol content of meats and to food preparation methods. ...
... as extremely important nutritionally and studied extensively. A ... scientists has revealed new findings about how carotenoids ... to tag carotenoids from kale, researchers at the ... monitored the nutrients' absorption within the body. Physiologist ...
... topic in the health fraternity these days. ,A survey ... concerned about trans-fats than carbohydrates.// ,Among the ... trans-fats, which had been known to raise bad cholesterol ... the US. In comparison, 10 percent strongly wanted to ...
Cached Medicine News:Health News:Bird Flu Survivor Recounts her ‘hell 2Health News:Researchers Identify Sipa 1 Gene, Responsible For Cancer Metastasis 2Health News:Association Of Breast Arterial Calcifications With Diabetes And Hypertension 2Health News:Intake Of Processed Meat And Fat Associated With Pancreatic Cancer 2Health News:Carotenoid Absorption Explained In A Better Manner 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: